Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: UNIVERSITY OF MARYLAND, BALTIMORE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2026-09-29
Current total value of award: $9161697
Description: EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: "ADJUVANT DEVELOPMENT OF THE TLR4 LIGAND BECC470S FOR USE IN INFLUENZA, S. AUREUS, AND P. AERUGINOSA VACCINES"